Lymphoproliferative disorders in pediatric liver allograft recipients
Authors:
- Hossein KhedmatHKHossein Khedmat
- Saeed TaheriSTSaeed Taheri
Open Access
- 1 April 2012
- journal article
- Published by Wolters Kluwer Health in Hematology/Oncology and Stem Cell Therapy
- Vol. 5 (2) , 84-90
Abstract
BACKGROUND AND OBJECTIVES: Due to the limited incidence of posttransplant lymphoproliferative disorders (PTLD) in pediatric liver graft recipients, there is a scarcity of data on the characteristics of the disease in this population. We aimed to analyze the special features and behavior of PTLD arising after pediatric liver transplantation. DESIGN: A comprehensive search of the literature was conducted for the available data on PTLD in pediatric liver recipients pediatric PTLD through a search of Pubmed and Google scholar using appropriate terms. METHODS: We sought data on liver recipients younger than 18 years of age at the time of transplantation. From 51 reports, 43 fulfilled the inclusion criteria. overall 250 cases of PTLD (212 pediatric PTLD) were found from 43 reports. Data on pediatric patients was compared to adults. RESULTS: Pediatric PTLD lesions were more likely of the polymorphic type (P=.004) and polyclonal (when age cut-off was defined at 12 years; P=.023). Remission rates, metastasis frequency and organ involvements were not different between the groups (P>.1 for all). survival analysis showed no disparity between pediatric PTLD and adult patients (P>.1); but when data was reanalyzed for patients surviving at least 4 months post diagnosis, the log rank test showed that pediatric patients have a superior outcome compared to adults (P=.045). CONCLUSIONS: Pediatric liver recipients developing PTLD have relatively better disease presentation and behavior than that in adults. stomach involvement was also more frequently seen in patients younger than 12 years, and should be more intensively evaluated. Future studies with a prospective approach and larger population size are needed for confirming our results.Keywords
This publication has 49 references indexed in Scilit:
- Hepatic involvement by lymphoproliferative disorders post liver transplantation: PTLD.Int. SurveyHepatology International, 2011
- Early versus late outset of lymphoproliferative disorders post-heart and lung transplantation: The PTLD.Int SurveyHematology/Oncology and Stem Cell Therapy, 2011
- Timing of Epstein-Barr Virus Acquisition and the Course of Posttransplantation Lymphoproliferative Disorder in ChildrenTransplantation, 2009
- Early Posttransplant Lymphoproliferative Disease in Pediatric Liver Transplant RecipientsTransplantation Proceedings, 2006
- Epstein–Barr virus‐related lymphoproliferation in children after liver transplant: Role of immunity, diagnosis, and managementPediatric Transplantation, 2002
- The Role of Quantitative Epstein-Barr Virus Polymerase Chain Reaction and Preemptive Immunosuppression Reduction in Pediatric Liver Transplantation: A Preliminary ExperienceJournal of Pediatric Gastroenterology and Nutrition, 2001
- Verotoxin targets lymphoma infiltrates of patients with post-transplant lymphoproliferative diseaseLeukemia Research, 2000
- Adenotonsillar Enlargement in Pediatric Patients Following Solid Organ TransplantationJAMA Otolaryngology–Head & Neck Surgery, 2000
- MANAGEMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS RECEIVING PRIMARY TACROLIMUS (FK506) THERAPYTransplantation, 1998
- B-cell lymphoproliferative disorders in solid-organ transplant patients: Detection of Epstein-Barr virus by in situ hybridizationHuman Pathology, 1992